Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001085420 | SCV001019685 | likely benign | Renal coloboma syndrome; Focal segmental glomerulosclerosis 7 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000144385 | SCV001986640 | uncertain significance | not provided | 2018-10-04 | criteria provided, single submitter | clinical testing | Has been reported previously in an individual with retinal dystrophy (Carss et al., 2017); Has also been reported previously in an unaffected parent of a child anophthalmia but was not observed in the affected child (Gelb et al., 2001; Bower et al., 2012); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; In addition, in silico splice predictors suggest this variant may lead to abnormal gene splicing; This variant is associated with the following publications: (PMID: 11180607, 22213154, 28041643) |
Clin |
RCV000144385 | SCV000189509 | not provided | not provided | no assertion provided | not provided | ||
NIHR Bioresource Rare Diseases, |
RCV000504921 | SCV000599128 | likely pathogenic | Retinal dystrophy | 2015-01-01 | no assertion criteria provided | research | |
Prevention |
RCV004544325 | SCV004763555 | benign | PAX2-related disorder | 2021-04-15 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |